Will NMD Policy Unleash Sector's Full Potential?
National Medical Devices Policy 2023 boosts industry confidence, promising growth and win–win benefits for manufacturers and patients.
Read More
AMD-CF will play important role in attracting investments in MedTech space: MTaI
MTaI welcomes the AMD-CF scheme, saying it will attract domestic and foreign investment and strengthen India’s medtech clusters.
Read More
Diplomats France, Germany, Canada, UK explore medtech business prospects in India
MTaI hosted a high-level roundtable in New Delhi where medtech leaders and diplomats explored collaboration and new business opportunities.
Read More
Union Budget 2023-24: Multidisciplinary courses for medical devices well received by industry
FM’s plan for multidisciplinary medtech courses may boost skilled manpower; industry hopes training centres get easy access to latest tech.
Read More
Healthcare tech industry body seeks cut in customs duty, removal of health cess on medical devices in Budget
Ahead of Budget 2023, MTaI urges cuts in customs duty and health cess on imported devices, citing high costs and patient affordability.
Read More
Thousands of contact lens businesses face disruption due to unpreparedness in sale licensing requirements: MTaI
MTaI welcomes CDSCO’s GSR 754(E) easing device sale licences, but urges clear mechanisms and transition time for compliance.
Read More
Rupee likely to remain under pressure in near term, says experts
Rupee hit a new low, closing at 82.32/$, down 15 paise, pressured by high crude, Fed hikes, and a widening trade deficit; downside likely.
Read More
MTaI urges the government not to levy TDS on free medical samples to doctors and clinicians
MTaI urges govt to reconsider TDS on free medical samples, warning it could disrupt the medtech sector and wider healthcare delivery.
Read More
MTaI seeks removal of additional 5% tax on imported medical devices
MTaI urges Budget 2023–24 to cut device import duty to 2.5% and remove 5% health cess to improve patient access and affordability.
Read More